arrow
Back
F

Fabrizio Schifano

university of hertfordshire

65H-index
456Paper Count
1.5WCitation Count
Published Papers 133
Publication Date
Possible Signals of Ocular Disorders Associated with Gabapentinoids: A Three-Arm Study
err2026-08-14
err0
errOAAI
errMya Murray; Amira Guirguis; Paul Deslandes; John Martin Corkery; Stefania Chiappini; Mariacristina Parravano; Fabrizio Schifano
errShare
errSave
errShare
errSave
Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
err2026-04-06
err0
errOAAI
errStefania Chiappini; John Martin Corkery; Amira Guirguis; Alessio Mosca; Mya Murray; Davide Arillotta; Luigi Dattoli; Giovanni Martinotti; Stefania Bonaccorso; Fabrizio Schifano; Nicolò Schifano
errShare
errSave
Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based Evidence
err2026-04-01
err0
errOAAI
errSpecka, Michael; Christensen, Stefan; Buggisch, Peter; Heyne, Renate; Naumann, Uwe; Klinker, Hartwig; Link, Ralph; Schmidt, Christiane Sybille; Schulte, Bernd; Reimer, Jens; Schifano, Fabrizio; Wedemeyer, Heiner; Scherbaum, Norbert
errShare
errSave
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications; An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database
err2026-03-03
err0
errOAAI
errStefania Chiappini; Laura Orsolini; John Martin Corkery; Amira Guirguis; Alessio Mosca; Davide Arillotta; Giovanni Martinotti; Fabrizio Schifano
errShare
errSave
Novel Synthetic Opioids (NSOs) and Their Evolving Crisis: Utilising NPSfinder® as a Real-Time Predictive Tool
err2025-12-21
err0
errOAAI
errElena Deligianni; Davide Arillotta; Alessandro Vento; John Martin Corkery; Georgios Papazisis; Antonis Goulas; Lisa Lione; Fabrizio Schifano
errShare
errSave
Managing Dual Diagnosis Patients and the Importance of Assessing Capacity: Data from London Inpatient Services
err2025-11-24
err0
errOAAI
errIain Hyndman; Angelo Ricciardi; Olesya Ajnakina; Christian Lowe; Cemile Kalkan; Sofia Mota; Christos Theleritis; Stefano Ferracuti; Stefania Bonaccorso; Fabrizio Schifano
errShare
errSave
Focus on ‘Psychiatry and Addiction: A Multi-Faceted Issue’
err2025-10-20
err0
errOAAI
errFabrizio Schifano; Giovanni Martinotti; Norbert Scherbaum
errShare
errSave
Novel psychoactive substances (NPS) as a risk factor for psychosis: a systematic review of the literature
err2025-10-19
err0
errOAAI
errAlessio Mosca; Gianluca Mancusi; Stefania Chiappini; Andrea Miuli; Clara Cavallotto; John Martin Corkery; Gilberto Di Petta; Arianna Pasino; Maria Chiara Santovito; Carlotta Marrangone; Maria Chiara Vicinelli; Mauro Pettorruso; Giovanni Martinotti; Fabrizio Schifano
errShare
errSave
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes
err2025-10-01
err0
errOAAI
errAlessio Mosca; Stefania Chiappini; Andrea Miuli; Clara Cavallotto; Mauro Pettorruso; Giovanni Martinotti; Fabrizio Schifano
errShare
errSave
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and “Smart Drug” Use and Misuse
err2025-09-29
err0
errOAAI
errFabrizio Schifano; Stefania Bonaccorso; Davide Arillotta; John Martin Corkery; Giuseppe Floresta; Gabriele Duccio Papanti Pelletier; Amira Guirguis
errShare
errSave
Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data
err2025-05-15
err0
errOAAI
errChiappini, Stefania; Mosca, Alessio; Pelletier, Duccio G. Papanti; Corkery, John M.; Guirguis, Amira; Arillotta, Davide; Martinotti, Giovanni; Schifano, Fabrizio
errShare
errSave
PHARMACOVIGILANCE SIGNALS OF SEMAGLUTIDE AND OTHER GLP-1 RECEPTOR AGONISTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION (FDA) ADVERSE EVENTS REPORTING SYSTEM (FAERS) DATASET
err2025-02-12
err0
errOAAI
errChiappini, Stefania; D'andrea, Giacomo; Cavallotto, Clara; Mosca, Alessio; Di Carlo, Francesco; Pettorruso, Mauro; Martinotti, Giovanni; Schifano, Fabrizio
errShare
errSave
EXAMINING LURASIDONE EFFICACY IN SCHIZOPHRENIC PATIENTS WITH COMORBID ALCOHOL AND SUBSTANCE USE DISORDER: A MULTICENTRIC PROSPECTIVE INVESTIGATION
err2025-02-12
err0
errOAAI
errChiappini, Stefania; Cavallotto, Clara; D'andrea, Giacomo; Cesare, Andrea Di; Mosca, Alessio; Carlo, Francesco Di; Pettorruso, Mauro; Martinotti, Giovanni; Schifano, Fabrizio
errShare
errSave
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective
err2025-01-01
err0
PREAI
errChiappini, S.; Guirguis, A.; Schifano, N.; Corkery, J. M.; Semeraro, F.; Mosca, A.; D'Andrea, G.; Papanti, G. Duccio; Arillotta, D.; Floresta, G.; Martinotti, G.; Schifano, F.
errShare
errSave
Postmortem findings of organ damage in novel psychoactive substances users: A comprehensive review
err2024-12-01
err0
errOAAI
errBenedetti, Beatrice; Conte, Celeste; Bergamin, Eva; Di Santo, Riccardo; Ciasca, Gabriele; Corkery, John M.; Bassi, Marta; Corli, Giorgia; Bilel, Sabrine; Schifano, Fabrizio; Marti, Matteo; De-Giorgio, Fabio
errShare
errSave
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review
err2024-11-18
err2
errOAAI
errChiappini, Stefania; Gramuglia, Pietro Domenico; Mosca, Alessio; Cavallotto, Clara; Miuli, Andrea; Corkery, John Martin; Guirguis, Amira; Schifano, Fabrizio; Martinotti, Giovanni
errShare
errSave